Can happiness be inherited?
Oxford, UK, 14 May 2009 - A new article published in Elsevier’s journal Bioscience Hypotheses suggests that our feelings in our lifetime can affect our children.
Dr. Halabe Bucay suggests that a wide range of chemicals that our brain generates when we are in different moods could affect ‘germ cells’ (eggs and sperm), the cells that ultimately produce the next generation. Such natural chemicals could affect the way that specific genes are expressed in the germ cells, and hence how a child develops.
In his article in the latest issue of Bioscience Hypotheses, Dr Alberto Halabe Bucay of Research Center Halabe and Darwich, Mexico, suggested that the hormones and chemicals resulting from happiness, depression and other mental states can affect our eggs and sperm, resulting in lasting changes in our children at the time of their conception.
Brain chemicals such as endorphins, and drugs, such as marijuana and heroin are known to have significant effects on sperm and eggs, altering the patterns of genes that are active in them.
“It is well known, of course, that parental behavior affects children, and that the genes that a child gets from its parents help shape that child’s character.” said Dr. Halabe Bucay. “My paper suggests a way that the parent’s psychology before conception can actually affect the child’s genes.”
“This is an intriguing idea” commented Dr. William Bains, Editor of Bioscience Hypotheses. “We wanted to publish it to see what other scientists thought, and whether others had data that could support or disprove it. That is what our journal is for, to stimulate debate about new ideas, the more groundbreaking, the better.”
# # #
Notes to Editors:“Endorphins, personality, and inheritance: Establishing the biochemical bases of inheritance”
Bioscience Hypotheses, In Press, Corrected Proof, Available online 7 May 2009
Alberto Halabe Bucay. doi:10.1016/j.bihy.2009.03.003Copies of the full-text article are available to members of the press by contacting the Elsevier press office at firstname.lastname@example.org(London Stock Exchange), RUK and ENL (New York Stock Exchange).
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
+44 1865 843824